Clinical Trial: ONO-4915 in Patients With Primary Sjogren's Disease

U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07823790) titled 'ONO-4915 in Patients With Primary Sjogren's Disease' on Sept. 03.

Brief Summary: To evaluate the efficacy and safety of ONO-4915 in patients with primary Sjogren's disease

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Sjogren's Disease

Intervention: DRUG: ONO-4915

Subcutaneous administration

DRUG: Placebo

Subcutaneous administration

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ono Pharmaceutical Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....